An engineered substance P variant for receptor-mediated delivery of synthetic antibodies into tumor cells.
An engineered substance P variant for receptor-mediated delivery of synthetic antibodies into tumor cells. Proc Natl Acad Sci U S A. 2009 Jul 07; 106(27):11011-5.